Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Yaffe

Showing results (251-260 of 370) with videos related to

Pageof 37
Sort By:
Molecular Cancer Therapeutics|June 11, 2009
The antiproliferative cytostatic effects of a self-activating viridin prodrugAdam Smith, Joseph Blois, Hushan Yuan, et al.
Nature Communications|January 27, 2024
Activation of GPR3-β-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesisTing Dong, Guangan Hu, Zhongqi Fan, et al.
Journal of Thrombosis and Haemostasis : JTH|April 9, 2020
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case seriesJanice Wang, Negin Hajizadeh, Ernest E Moore, et al.
The Pediatric Infectious Disease Journal|June 1, 1996
Cytomegalovirus infections in Toronto child-care centers: a prospective study of viral excretion in children and seroconversion among day-care providersE L Ford-Jones, I Kitai, L Davis, et al.
World Journal of Emergency Surgery : WJES|April 22, 2020
Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysisRashikh Choudhury, Christopher D Barrett, Hunter B Moore, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 7, 2014
Physiology of functional and effective networks in epilepsyRobert B Yaffe, Philip Borger, Pierre Megevand, et al.
The EMBO Journal|December 16, 2000
TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteinsF Kanai, P A Marignani, D Sarbassova, et al.
Science Signaling|May 15, 2014
A nanoparticle-based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathwaysStephen W Morton, Michael J Lee, Zhou J Deng, et al.
Cancer Research|August 4, 2006
ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in miceAl Charest, Erik W Wilker, Margaret E McLaughlin, et al.
Science Signaling|October 19, 2021
The injury response to DNA damage in live tumor cells promotes antitumor immunityGanapathy Sriram, Lauren E Milling, Jung-Kuei Chen, et al.
Pageof 37

Showing results (251-260 of 370) with videos related to

Sort By:
Pageof 37
Molecular Cancer Therapeutics|June 11, 2009
The antiproliferative cytostatic effects of a self-activating viridin prodrugAdam Smith, Joseph Blois, Hushan Yuan, et al.
Nature Communications|January 27, 2024
Activation of GPR3-β-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesisTing Dong, Guangan Hu, Zhongqi Fan, et al.
Journal of Thrombosis and Haemostasis : JTH|April 9, 2020
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case seriesJanice Wang, Negin Hajizadeh, Ernest E Moore, et al.
The Pediatric Infectious Disease Journal|June 1, 1996
Cytomegalovirus infections in Toronto child-care centers: a prospective study of viral excretion in children and seroconversion among day-care providersE L Ford-Jones, I Kitai, L Davis, et al.
World Journal of Emergency Surgery : WJES|April 22, 2020
Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysisRashikh Choudhury, Christopher D Barrett, Hunter B Moore, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 7, 2014
Physiology of functional and effective networks in epilepsyRobert B Yaffe, Philip Borger, Pierre Megevand, et al.
The EMBO Journal|December 16, 2000
TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteinsF Kanai, P A Marignani, D Sarbassova, et al.
Science Signaling|May 15, 2014
A nanoparticle-based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathwaysStephen W Morton, Michael J Lee, Zhou J Deng, et al.
Cancer Research|August 4, 2006
ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in miceAl Charest, Erik W Wilker, Margaret E McLaughlin, et al.
Science Signaling|October 19, 2021
The injury response to DNA damage in live tumor cells promotes antitumor immunityGanapathy Sriram, Lauren E Milling, Jung-Kuei Chen, et al.
Pageof 37